Cite
HARVARD Citation
Cheknis, A. et al. (2020). Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities. Journal of antimicrobial chemotherapy. pp. 3120-3125. [Online].